Cardiff Oncology
CRDF
CRDF
115 hedge funds and large institutions have $39.7M invested in Cardiff Oncology in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
19% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 37
48% less capital invested
Capital invested by funds: $76.6M → $39.7M (-$36.8M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
115
Holding in Top 10
–
Calls
$1.19M
Puts
$118K
Top Buyers
| 1 | +$643K | |
| 2 | +$208K | |
| 3 | +$157K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$145K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$136K |
Top Sellers
| 1 | -$2.11M | |
| 2 | -$1.06M | |
| 3 | -$968K | |
| 4 |
Goldman Sachs
New York
|
-$512K |
| 5 |
ACA
Acorn Capital Advisors
New York
|
-$411K |
